Genetic deletion of Kvβ2 (AKR6) causes loss of muscle function and increased inflammation in mice

Introduction

The voltage-gated potassium (Kv) channels are transmembrane channels selective to K⁺ and belong to the larger ion channel families (Gutman et al., 2003). The Kv channels modulate action potential shape and duration in a variety of tissues, including skeletal and cardiac muscles (Nerbonne, 2016; Kilfoil et al., 2019). The human genome encodes 40 Kv channels that are classified into 12 groups based on their amino acid sequence homology (Kv1-12) with diverse physiological functions (Wulff et al., 2009). The α-subunits form homo- or heterodimers and can also associate with cytoplasmic β-subunits (Long et al., 2005). The voltage gated Kv channels (Kv1,4,7) influence the threshold and number of action potentials generated during depolarization or excitatory synaptic potentials. Whereas Kv2 and Kv3 modulate the duration and firing pattern of the action potentials. The kinetics of Kv channels also influence the action potentials generated. The Kv channels also play a role in calcium signaling, cell proliferation, migration, differentiation, cell death and maintenance of cell volume (Bachmann et al., 2020). Deficiency of Kv channels leads to neurological and metabolic disorders, cardiovascular and autoimmune diseases, cancer, and deafness (Glasscock et al., 2010; Leitner et al., 2011; Anderson et al., 2019; Trosclair et al., 2021). Therapeutically, the Kv channel activators or blockers alter the action potential’s firing pattern (Vyas et al., 2019).

Skeletal muscle is a major tissue comprising around 40% of the total body mass in humans. Skeletal muscle is also an active metabolic organ and helps in movement through contraction and relaxation of the myofibrillar proteins upon nervous stimulation. It has high tissue plasticity to adapt to varying conditions such as exercise, pathophysiological states, and aging (Manickam and Wahli, 2017). Sarcopenia, the age-associated decline in muscle mass and mechanical function, occurs in the context of chronic inflammation, mitochondrial dysfunction, metabolic deregulation, reduced stem cell number and function, and altered gene expression (Larsson et al., 2019). In a previous study, we demonstrated that loss of Kvβ2 leads to decrease muscle size and mass, and therefore in the present study we evaluated the effect of Kvβ2 deletion on muscle strength and impact in both young and aging mice.

The Kvβ subunits 1–3/KCNAB family of Kv channels belong to NADPH-dependent aldo-keto reductases (AKR) and bind to NADPH-cofactors. These Kvβ subunits form complexes with Kv1 and Kv4 channels α-subunits and modulates the gating and kinetics of Kv channels, membrane localization, and their redox sensitivity (Bähring et al., 2001; McCormack et al., 2002; Tipparaju et al., 2008). The expression of different Kvβ subunits such as Kvβ1.1–1.3, and Kvβ2 plays an important role in skeletal muscle development and physiology (Grande et al., 2003). Intriguingly, the deletion of Kvβ2 in mice leads to decreased life span, increased seizures and cold-induced tremors (McCormack et al., 2002). Previously, we reported that deletion of Kvβ2 in mice led to reduce body weight, hindlimb muscle mass and size, and decreased muscle stem cells marker Pax7 protein levels, with increased Nedd4, Calcineurin, and MHC1 and MHC2a protein levels (Grande et al., 2003; Chapalamadugu et al., 2018). We also demonstrated that Kvβ2 is involved in cardiomyocyte repolarization and metabolism (Kilfoil et al., 2019), and that deletion of Kvβ2 in mice decreases isoproterenol-induced heart muscle injury and circadian clock genes (Tur et al., 2021). Therefore, we hypothesized that deletion of Kvβ2 in mice not only affects the skeletal muscle mass but also its contractile function and grip strength.

Materials and methods

Animals

The hemizygous Kvβ2^+/− null mice were a generous gift from Dr. Geoffrey Murphy (University of Michigan, MI, United States). The Kvβ2^+/− null mice were interbred to generate the age-matched wildtype (WT) and Kvβ2^−/− knockout (KO) mice as described previously (McCormack et al., 2002). All mice were fed with food and water ad libitum, and were maintained at Morsani College of Medicine, University of South Florida, FL, United States. The young (14–20 weeks) and old (1–2 years) WT and KO male mice were used in this study. All animal work was approved before the start of the study by the Institutional Animal Care and Use Committee (IACUC) at the University of South Florida, FL, United States.

Grip strength

The forelimb grip strengths of 14–16 weeks and 50–58 weeks old WT and KO mice were measured with Chatillon force measurement DFE II grip strength meter (Ametek, Columbus Instruments, OH, United States) as described previously (Manickam et al., 2022). Five individual measurements were recorded per mouse and is represented as the average grip strength expressed as KGF/Kg body weight, where n = 6–15 mice/group.

Myofiber force frequency relationship

The ex vivo contractility and force-frequency relationship (FFR) were measured as described previously (Manickam et al., 2022). Briefly, the extensor digitorum longus (EDL) muscles from both hindlimbs were collected after euthanizing the mice in compliance with the University of South Florida, IACUC guidelines. Immediately after dissecting the EDL free, it was tied with surgical suture to a force transducer in buffer containing 137 mM NaCl, 0.4 mM NaH₂PO₄, 5.1 mM KCl, 1.05 mM MgCl₂, 2.0 mM CaCl₂, and 10 mM glucose at pH 7.4 in the bath maintained at 22°C and continuously aerated with 95% O₂/5% CO₂. After equilibration the optimal muscle length (l₀) for each muscle was calculated and subjected to stimulation trains (500 ms) of frequencies ranging from 1 to 125 Hz, 1 per minute to determine the force-frequency relationship. The stimulation was delivered with S48 stimulators (Grass Products, RI, United States), and all pulses were 1 ms in duration. The peak forces of each contraction at the different stimulation frequencies were used to plot the FFR. The FFR was expressed in both absolute (mN) and normalized (mN/mg muscle mass) terms, with n = 4–7 mice/group.

Transmission electron microscopy

The transmission electron microscopy (TEM) images were obtained as described previously (Manickam et al., 2022). Briefly, the hindlimb EDL muscles were dissected and fixed immediately with 2.5% glutaraldehyde in 0.1 M sodium phosphate buffer for 2 h at room temperature (RT), and overnight at 4°C. Subsequent washes were carried out in phosphate buffer solution and then fixed with 1% osmium tetroxide in phosphate buffer for 2 h at 4°C. After rinsing in phosphate buffer, the muscles were then dehydrated in ethanol and acetone at RT and infiltrated in acetone: pure resin for 4 h and then embedded in the embedding wax. Polymerization of the embedding mix was carried out at 70°C overnight. 1 µm and 70 nm thin sections were cut with Reichert Ultracut microtome, stained with 2% uranyl acetate, and contrasted with lead citrate as per standard protocol. Images were obtained at x15,000, ×30,000 and ×50,000 magnifications with JOEL1400 transmission electron microscope. The myofibrillar sarcomere lengths were analyzed at ×30,000 magnified images and quantified using ImageJ software, where n = 3 mice/group. 7–14 images were analyzed per mouse with a total of 184 and 191 myofibrils for the young WT and KO mice, respectively. For quantification, the yellow lines were drawn from one Z-line to the next Z-line of the I bands using NIH ImageJ software to measure the length of myofibrils sarcomeres.

Van Gieson staining

The hindlimb tibialis anterior (TA) muscles were dissected out from the young and old WT and KO mice and embedded in optimal cutting temperature (OCT) medium and frozen in isopentane chilled in liquid nitrogen and stored at −80°C. 10 µm thick transverse serial cryosections were cut at the mid-belly region using Leica (CM1860) cryostat machine and stained with Weigert’s iron hematoxylin for 10 min at RT. After washing with tap water, the sections were left in picrofuchsin solution for 20 min at RT. Washes were done with graded ethanol with picric acid, and finally with 100% ethanol until clear. The sections were then cleared with xylene for 5 min twice at RT and mounted with DPX mountant. Montage images were obtained at ×10 magnifications with Olympus IX73 inverted microscope using CellSens Standard software (Olympus Soft Imaging Solution, United States). Quantification of the fibrotic tissues area (red color) was carried out with ImageJ software (NIH, United States), where n = 3 mice/group. The representative images were taken at ×20 magnification.

Quantitative real-time polymerase chain reaction

Total RNA was isolated from the hindlimb gastrocnemius (GAS) muscles of the young and old WT and KO mice using Exiqon miRCURY RNA isolation kit (Exiqon, MA, United States) as per manufacturer’s recommendation. cDNA was synthesized from the isolated total RNA using iScript cDNA synthesis kit (Bio-Rad Laboratories, CA, United States). Il6 expression was measured with iTaq Universal SYBR Green Supermix with CFX96 Real-Time C1000 Touch Thermal Cycler System (Bio-Rad Laboratories, CA, United States). The cDNA synthesis and qPCR procedures were performed as described previously (Chapalamadugu et al., 2018). The mouse GAPDH was used as an internal control reference gene, where n = 5–8 mice/group.

Whole transcriptomic sequencing (RNA seq)

The hindlimb GAS muscles whole transcriptome sequencing was carried out as described previously (Manickam et al., 2022). Total RNA was extracted from the GAS muscles of young WT and KO mice, and the RNA quality and integrity were determined. RNA Seq library was then prepared. The cDNA library quality was determined before sequencing with Illumina PE150 platform. The data generated were analyzed between the WT and KO mice, where n = 3 mice/group for bioinformatics analysis.

Bioinformatics

RNA-Seq data was analyzed by using two open-source software programs: TopHat and Cufflinks (Trapnell et al., 2012). Raw reads were mapped to mice GRCm38 genome by using TopHat. Cufflinks quantified genes across WT and KO groups to find differentially expressed genes (q value < 0.05) between these two groups. The differentially expressed genes were then entered into the Database for Annotation, Visualization, and Integrated Discovery (DAVID) (Sherman et al., 2022) to explore the KEGG gene pathways that are enriched in these genes.

Statistical analysis

Statistical analyses were performed with GraphPad Prism 9.5.1 or SigmaPlot software. An unpaired Student’s t-test was utilized when comparing only two groups. A 3-way ANOVA, with 2 between-subjects factors (age and genotype) and one repeated factor (frequency) was used to test the FFR. Data are represented as mean ± SD. Statistical significance was set at p < 0.05 for all data analyzed either with GraphPad Prism 9.5.1 or SigmaPlot software with post hoc tests.

Results

Genetic ablation of Kvβ2 in mice results in decreased body weight

Consistent with our previous publication, the young (20 weeks) Kvβ2 KO mice displayed a significant (p = 0.0215) decrease in body weight compared to littermate WT mice (Chapalamadugu et al., 2018). In the present study, we demonstrate that a similar significant (p = 0.0161) reduction in body weight was noticed in old (1.5–2 years) Kvβ2 KO mice compared with age-matched WT mice (Figures 1A, B). Together this suggests that the deletion of Kvβ2 in mice results in decreased body weight postnatally and during aging.

FIGURE 1

FIGURE 1. Genetic ablation of Kvβ2 in mice results in decreased body weight. (A) Body weight of young (20 weeks) and (B) old (1.5–2 years) wildtype (WT) and Kvβ2 knockout (KO) male mice in grams (g). Data are expressed as mean ± SD; *p < 0.05.

Deletion of Kvβ2 in mice results in decreased physical performance and muscle force-frequency relationship

Previously, we demonstrated that deletion of Kvβ2 in mice results in decreased hindlimb muscles size and mass, and the muscle stem cells marker Pax7 protein levels (Chapalamadugu et al., 2018). However, it was not known if those changes resulted in any alterations in skeletal muscle contractile function and grip strength. Therefore, in the present study we assessed the forelimb grip strength and ex vivo skeletal muscle force-frequency relationship (FFR) of the hindlimb EDL muscles as a measure of function in the age-matched WT and KO mice. Young (14–16 weeks) Kvβ2-KO mice displayed a significant (p = 0.0446) decrease in forelimb grip strength compared to age-matched WT mice (Figure 2A). A similar significant (p = 0.0417) reduction in the forelimb grip strength was also noticed during aging in the 50–58 weeks-old Kvβ2 KO mice compared to age-matched WT mice (Figure 2B). In addition, the young (Y-20 weeks) and old (O-2yr) Kvβ2 KO mice displayed a decrease in the hindlimb EDL muscles absolute and normalized FFR compared with age-matched WT mice. There was a significant effect of genotype (p < 0.001), and an age x genotype (p = 0.006) interaction (Figures 2C, D). Together, these data suggests that deletion of Kvβ2 in mice results in impaired muscle function both in vivo and ex vivo.

FIGURE 2

FIGURE 2. Decreased physical performance and myofiber force frequency of Kvβ2 KO mice. (A) Forelimb grip strength of young (14–16 weeks) and (B) old (50–58 weeks) wildtype (WT) and Kvβ2 knockout (KO) male mice. Data are expressed as mean ± SD; *p < 0.05. (C) The absolute force frequency, and (D) normalized force frequency of young (20 weeks) and old (2 years) WT and KO male mice hindlimb EDL muscles. The F statistics of the myofiber force frequencies with frequencies as a repeated measure displayed a significant effect on genotype (p < 0.001) and the age x genotype interactions (p = 0.006). Data are expressed as mean ± SD; where Y, Young; O, Old mice.

Decreased hindlimb skeletal muscle mass in Kvβ2 KO mice

Previously, we showed that deletion of Kvβ2 in young mice results in decreased mass of hindlimb muscles: biceps femoris, gastrocnemius, and soleus (Chapalamadugu et al., 2018). Here we show a similar significant decrease not only in the young (20 weeks) Kvβ2 KO mice hindlimb muscles EDL (p = 0.0343), GAS (p = 0.0056), and Quadriceps (QUAD) (p = 0.0001) but also in the old Kvβ2 KO mice EDL (p = 0.0213), GAS (p = 0.0021), and QUAD (p = 0.0003) muscles compared to age-matched WT mice (Figures 3A–F). In addition, the direct comparison of old (2 years) WT and young (20 weeks) Kvβ2 KO mice hindlimb muscles EDL (p = 0.4146), GAS (p = 0.1065), and QUAD (p = 0.1169) did not show any significant difference in their weights (Supplemental Figures S1A–C). This clearly suggests that the reduction in muscle mass in Kvβ2 KO mice leads to decreased hindlimb muscles grip strengths both in the young and old mice.

FIGURE 3

FIGURE 3. Deficiency of Kvβ2 in mice results in decreased hindlimb muscles weight. (A) The hindlimb EDL muscles weight of young (20 weeks) and (B) old (2 years) WT and KO male mice in milligrams (mg). (C) GAS muscles weight of young (20 weeks) and (D) old (2 years) WT and KO male mice in milligrams (mg). (E) The QUAD muscles weight of young (20 weeks) and (F) old (2 years) WT and KO male mice in milligrams (mg). Data are expressed as mean ± SD; *p < 0.05.

Kvβ2 regulates skeletal muscle fiber size

The transmission electron microscopy image analysis of the longitudinal sections of the hindlimb EDL muscles displayed a significant (p = 0.0086) reduction in myofibrils sarcomere length in the young (20 weeks) Kvβ2 KO mice compared to age-matched WT mice (Figures 4A–C). In addition, a significant reduction in the myofiber cross-sectional area of the medium (2,000–4,000 µm²) (p = 0.0016) and largest (>4,000 µm²) (p = 0.0009) sized myofiber areas was also observed in the young (20 weeks) Kvβ2 KO mice hindlimb TA muscles cryosections stained with hematoxylin and eosin (H&E) compared to age-matched WT mice (Figures 4D, E), These results further confirm that deletion of Kvβ2 in mice results in decreased hindlimb muscle mass.

FIGURE 4

FIGURE 4. Reduced sarcomere length and myofiber size of Kvβ2 KO mice. Representative images of transmission electron microscopy of the hindlimb EDL muscles of young (20 weeks) (A) WT and (B) KO male mice. (C) Quantification of the EDL myofibrils sarcomere length (marked in yellow lines from one Z-line to the next Z-line [red arrow heads] of the I-bands [red lines] of the sarcomere) of WT and KO mice, where n = 184 and 191, respectively. (D,E) Quantification of 250 random myofibers cross-sectional areas of hematoxylin and eosin-stained TA muscles, where n = 3 mice/group x 3 sections/mouse. Data are expressed as mean ± SD; *p < 0.05; ns, non-significant.

The young Kvβ2 KO mice phenocopy inflammaging phenotype

We then assessed the inflammaging phenotype of the skeletal muscles of the young (20 weeks) and old (2 years) mice through Van Gieson staining (fibrosis) of the hindlimb TA muscles cryosections and expression of the proinflammatory marker Il6 through RT-qPCR. Deletion of Kvβ2 displayed a significant (p = 0.0103) increase in fibrotic tissue area in the young (20 weeks) mice compared to age-matched WT mice, whereas it was found to be non-significant (p = 0.3081) in the old mice between the genotypes (Figures 5A–C). This was accompanied by a significant (p = 0.0008) increase in the proinflammatory marker Il6 expression in the young (20 weeks) Kvβ2 KO mice compared to age-matched WT mice (Figure 5D). However, the expression levels Il6 was found to be non-significant (p = 0.1699) in the 2 years old WT and KO mice (Figure 5E).

FIGURE 5

FIGURE 5. Deletion of Kvβ2 results in increased skeletal muscle tissue fibrosis in young mice. (A) Representative ×20 magnification images of the hindlimb TA muscles cross-sections at mid-belly region of young (20 weeks) and old (2 years) WT and KO male mice stained with Van Gieson stain. (B) Quantification of fibrotic tissues area (red color) of young (20 weeks) and (C) old (2 years) WT and KO male mice stained with Van Gieson stain, where n = 3 mice/group whole sections. (D) RT-qPCR analysis of Il6 expression levels in young (20 weeks) and (E) old (2 years) WT and KO male mice, where n = 5−8 mice/group. Data are expressed as mean ± SD; *p < 0.05, ns, non-significant.

Deletion of Kvβ2 in mice results in enhanced skeletal muscle atrophy, inflammation, altered metabolism, and circadian clock genes expression

To evaluate the differential gene expression of the young Kvβ2 KO and WT mice, RNA Seq analysis was performed in the hindlimb GAS muscles. The volcano plot shows the number of differentially expressed key genes (Figure 6A) that were significantly (p < 0.05) upregulated (384 genes) and downregulated (40 genes) in the young Kvβ2 KO mice compared to age-matched WT mice. Subsequent heat map analysis of the differentially expressed key genes in the young Kvβ2 KO and WT mice displayed a significant (p < 0.05) increase in the expression of genes involved in skeletal muscle development, cell proliferation and determination (Myo1d, Notch1, and Notch4), muscle atrophy (Trim54, Hdac5, Sumo2, Acvr1b, and N4bp3), energy metabolism and muscle plasticity (Irs2, Akt1, Ucp2, Fndc5, Plin3, Plin4, Ppara, and Ppard), and inflammation (Il6ra and Il34), and a decrease in circadian core clock (Clock and Arntl) genes along with an increase in the negative feedback loop clock gene repressors such as Per1, Per2 and Cry2 in young Kvβ2 KO mice compared to age-matched WT mice. However, there was also a decrease in Acvr2a, Cry1 and Il1r1 genes expression in the young Kvβ2 KO mice compared to age-matched WT mice (Figure 6B) suggesting the differential regulation of various signaling pathways involved in muscle atrophy, peripheral circadian rhythm and inflammation between the genotypes (Figures 6C, D).

FIGURE 6

FIGURE 6. RNA Seq data analysis of the hindlimb GAS muscles of young (20 weeks) WT and KO mice. (A) Volcano plot showing differentially expressed genes in the KO_vs._WT mice. (B) Heat map of the key genes that are differentially expressed in the KO_vs._WT mice. (C) Signaling pathways that are downregulated and (D) upregulated in the KO_vs._WT mice. Data are expressed as significantly different where q < 0.05, and n = 3 mice/group.

Discussion

The voltage-gated potassium channel β2 subunit (Kvβ2) has been implicated in many physiological functions, however, its role in skeletal muscle function remains unknown. Therefore, in the present study we sought to test the effect of Kvβ2 deletion on mouse skeletal muscle function. We report three major changes in the mouse skeletal muscle based on the deletion of Kvβ2 in mice: 1) deletion of Kvβ2 leads to decreased muscle function, 2) genetic deletion of Kvβ2 leads decreased myofibrils sarcomere length and myofiber cross-sectional area and 3) RNA seq analysis provides insights into the differential gene expression patterns that are consistent with muscle atrophy, inflammation, altered energy metabolism and circadian rhythm.

Based on the study, we demonstrate that there was reduced forelimb grip strength in the young Kvβ2 KO mice, which was also apparent during aging in these mice. Previously, we reported that the deletion of Kvβ2 in mice leads to reduced hindlimb muscle and body weights with decreased Pax7 protein levels during postnatal growth (Chapalamadugu et al., 2018). Here, we confirm a robust reduction in the hindlimb muscles and body weights in young Kvβ2 KO as well as in old Kvβ2 KO mice. Consistent with our previous finding, we also found a similar reduction in the medium to largest diameter sized myofibers area in the hindlimb TA muscles cross-sections of the young Kvβ2 KO mice analyzed (Chapalamadugu et al., 2018). Similarly, the transmission electron microscopy image analysis of the hindlimb EDL muscles longitudinal sections also revealed a decrease in the myofibrils sarcomere length in the young Kvβ2 KO mice suggesting plausible myofiber atrophy. Together, this suggests that the observed decline in the muscle function might be due to its direct association with the decreased muscle weights. To address this question, we utilized the ex vivo hindlimb EDL myofibers force-frequency relationship and found that the deletion of Kvβ2 in mice leads to decreased absolute and normalized EDL myofibers FFR both in the young and old Kvβ2 KO mice, suggesting that muscle function is compromised by loss of muscle mass as well as the decreased length of the sarcomere.

Intriguingly, the young Kvβ2 KO mice displayed an increase in fibrotic tissue area in hindlimb TA muscles cross-sections stained with Van Gieson’s staining but was found to be non-significant between the genotypes in the old mice as the aged WT mice also displayed an increase in the fibrotic tissue area consistent with the aging muscle phenotype. To test this, we performed an in-depth RNA-Seq analysis of the differentially expressed genes in the hindlimb GAS muscles of the young Kvβ2 KO_vs._WT mice. The volcano plot analysis identified 384 and 40 genes to be up- and downregulated in the Kvβ2 KO mice, respectively. Subsequent, heat map analysis revealed an increase in the expression of number of key genes involved in skeletal muscle development, proliferation and cell fate determination (Notch signaling), atrophy (Neurogenic), inflammation (Interleukins), energy metabolism and muscle plasticity (Ppars and Insulin signaling), along with a decrease in the circadian peripheral core clock genes (Clock and Bmal1/Arntl) and an increase in the negative feedback loop core clock gene repressors (Per and Cry) reflective of impaired muscle phenotype (Luo et al., 2005; Perera et al., 2012; Manickam and Wahli, 2017). Noticeably, we showed previously the downregulation of circadian core clock Bmal1 gene expression in the cardiac tissue samples of the young Kvβ2 KO mice (Tur et al., 2021). In addition, we also validated the pro-inflammatory Il6 myokine expression through real-time quantitative PCR analysis of the hindlimb GAS muscles of the young and old Kvβ2 KO mice and found that Il6 expression was higher in both the young and old Kvβ2 KO mice.

Previously, we showed that deletion of Kvβ2 in mice enhanced NEDD4 levels and decreased PAX7 protein levels in skeletal muscle during postnatal myogenesis (Chapalamadugu et al., 2018) suggesting that Nedd4 might negatively regulate Pax7 expression in the young Kvβ2 KO mice. In this study we show an increase in NEDD4 ubiquitin ligase binding protein 3 (N4bp3) expression in the young Kvβ2 KO mice. We also found that deletion of Kvβ2 in mice leads to an increase in Myo1d (Myosin1d), along with an increase in Notch 1 and 4 expression levels in the Kvβ2 KO mice, suggesting that there might be an increase in the early progenitor population in these mice (Luo et al., 2005). In addition, we also noticed an increase in the Acvr1b, Hdac5, and Trim54/MuRF3 expression levels in the Kvβ2 KO mice suggesting possible activin receptor signaling, and neurogenic muscle atrophy of skeletal muscles in these mice leading to reduced muscle mass, grip strength, the contractile unit sarcomere length, myofiber size, and increased fibrosis (Moresi et al., 2010; Lee et al., 2020). Furthermore, the circadian core clock genes Clock and Arntl/Bmal1 expression was found to be downregulated in the Kvβ2 KO mice with a simultaneous increase in the negative feedback loop core clock gene repressors Per1, Per2, and Cry2 expression levels, which clearly indicates the involvement of peripheral circadian clock genes in the Kvβ2 KO mice (Sadria and Layton, 2021). There was also an increase in the pro-inflammatory markers such as Il34, Il6ra, and a decrease in the Il1r1 agonist/antagonist receptor suggesting that there is increased inflammation in the skeletal muscles of the young Kvβ2 KO mice. Additionally, we also noticed an increase in the expression of genes involved in energy metabolism and muscle plasticity such as Ppars (Ppar-α and Pparδ) and insulin (Irs2/Akt1) signaling, lipid droplets associated proteins (Plin3, 4), browning of adipose tissues (Fndc5, Ucp2), and a decrease in the small ubiquitin-like modifier 2 (Sumo2) in the young Kvβ2 KO mice. Interestingly, there was also an increase in the longevity associated pathway, i.e., the NAD⁺-dependent protein deacetylase Sirt6 expression in the Kvβ2 KO mice, which is implicated in cellular stress resistance, genomic stability, aging and energy homeostasis (Roichman et al., 2021). Collectively, these data suggest that the genetic ablation of Kvβ2 in mice results in the use of alternate energy metabolism to overcome the overt skeletal muscle phenotype observed in young adults.

Conclusion

The present study demonstrates that deletion of Kvβ2 decreased muscle mass and strength. The deletion of Kvβ2 in mice also resulted in increased fibrotic tissues area in the young Kvβ2 KO mice along with an increase in the proinflammatory markers. RNA Seq analysis showed increased expression of genes involved in muscle atrophy, energy metabolism, inflammation, and circadian rhythm. Overall, this is the first study linking kcnab2 gene to age related muscle function along with molecular insights into signaling pathways.

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material. GEO accession number GSE233996.

Ethics statement

The animal study was reviewed and approved by Institutional Animal Care and Use Committee (IACUC) at the University of South Florida, FL, United States.

Author contributions

Research concept: ST; experiments: RM, JV, and DR; data analysis: RM, JV, AP, DR, FC, and ST; manuscript: RM and ST. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the National Institutes of Health, DK119066, the William Saunders Chair in Geriatric Pharmacotherapy grant fundings to ST. R01AG070145 (to WX).

Acknowledgments

The authors thank Ms. Vivian Puig for technical assistance, Dr. Puja Sinha for mouse tissue and RNA Seq data at USF Genomics Core Laboratory, and Ms. Amanda Garces for the Transmission Electron Microscopy.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fragi.2023.1175510/full#supplementary-material

Supplemental Figure S1 | Comparison of hindlimb muscle weights in 2-year-old WT and 20-week young Kvβ2 KO mice. (A) EDL muscles weight. (B) GAS muscles weight. (C) QUAD muscles weight. Data are expressed as mean ± SD; ns, non-significant.

References

Anderson, K. J., Cormier, R. T., and Scott, P. M. (2019). Role of ion channels in gastrointestinal cancer. World J. Gastroenterol. 25, 5732–5772. doi:10.3748/wjg.v25.i38.5732

PubMed Abstract | CrossRef Full Text | Google Scholar

Bachmann, M., Li, W., Edwards, M. J., Ahmad, S. A., Patel, S., Szabo, I., et al. (2020). Voltage-gated potassium channels as regulators of cell death. Front. Cell. Dev. Biol. 8, 611853. doi:10.3389/fcell.2020.611853

PubMed Abstract | CrossRef Full Text | Google Scholar

Bähring, R., Milligan, C. J., Vardanyan, V., Engeland, B., Young, B. A., Dannenberg, J., et al. (2001). Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kvbeta subunits. J. Biol. Chem. 276, 22923–22929. doi:10.1074/jbc.M100483200

PubMed Abstract | CrossRef Full Text | Google Scholar

Chapalamadugu, K. C., Tur, J., Badole, S. L., Kukreja, R. C., Brotto, M., and Tipparaju, S. M. (2018). Physiological role of Kvβ2 (AKR6) in murine skeletal muscle growth and regulation. Acta Physiol. (Oxf) 224, e13083. doi:10.1111/apha.13083

PubMed Abstract | CrossRef Full Text | Google Scholar

Glasscock, E., Yoo, J. W., Chen, T. T., Klassen, T. L., and Noebels, J. L. (2010). Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy. J. Neurosci. 30, 5167–5175. doi:10.1523/JNEUROSCI.5591-09.2010

PubMed Abstract | CrossRef Full Text | Google Scholar

Grande, M., Suàrez, E., Vicente, R., Cantó, C., Coma, M., Tamkun, M. M., et al. (2003). Voltage-dependent K+ channel beta subunits in muscle: Differential regulation during postnatal development and myogenesis. J. Cell. Physiol. 195, 187–193. doi:10.1002/jcp.10203

PubMed Abstract | CrossRef Full Text | Google Scholar

Gutman, G. A., Chandy, K. G., Adelman, J. P., Aiyar, J., Bayliss, D. A., Clapham, D. E., et al. (2003). International union of pharmacology XLI. Compendium of voltage-gated ion channels: Potassium channels. Pharmacol. Rev. 55, 583–586. doi:10.1124/pr.55.4.9

PubMed Abstract | CrossRef Full Text | Google Scholar

Kilfoil, P. J., Chapalamadugu, K. C., Hu, X., Zhang, D., Raucci, F. J., Tur, J., et al. (2019). Metabolic regulation of Kv channels and cardiac repolarization by Kvβ2 subunits. J. Mol. Cell. Cardiol. 137, 93–106. doi:10.1016/j.yjmcc.2019.09.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., et al. (2019). Sarcopenia: Aging-Related loss of muscle mass and function. Physiol. Rev. 99, 427–511. doi:10.1152/physrev.00061.2017

PubMed Abstract | CrossRef Full Text | Google Scholar

Lee, S. J., Lehar, A., Meir, J. U., Koch, C., Morgan, A., Warren, L. E., et al. (2020). Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight. Proc. Natl. Acad. Sci. U. S. A. 117, 23942–23951. doi:10.1073/pnas.2014716117

PubMed Abstract | CrossRef Full Text | Google Scholar

Leitner, M. G., Halaszovich, C. R., and Oliver, D. (2011). Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate. Mol. Pharmacol. 79, 51–60. doi:10.1124/mol.110.068130

PubMed Abstract | CrossRef Full Text | Google Scholar

Long, S. B., Campbell, E. B., and Mackinnon, R. (2005). Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 309, 897–903. doi:10.1126/science.1116269

PubMed Abstract | CrossRef Full Text | Google Scholar

Luo, D., Renault, V. M., and Rando, T. A. (2005). The regulation of Notch signaling in muscle stem cell activation and postnatal myogenesis. Semin. Cell. Dev. Biol. 16, 612–622. doi:10.1016/j.semcdb.2005.07.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Manickam, R., Tur, J., Badole, S. L., Chapalamadugu, K. C., Sinha, P., Wang, Z., et al. (2022). Nampt activator P7C3 ameliorates diabetes and improves skeletal muscle function modulating cell metabolism and lipid mediators. J. Cachexia Sarcopenia Muscle 13, 1177–1196. doi:10.1002/jcsm.12887

PubMed Abstract | CrossRef Full Text | Google Scholar

Manickam, R., and Wahli, W. (2017). Roles of peroxisome proliferator-activated receptor β/δ in skeletal muscle physiology. Biochimie 136, 42–48. doi:10.1016/j.biochi.2016.11.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Mccormack, K., Connor, J. X., Zhou, L., Ho, L. L., Ganetzky, B., Chiu, S. Y., et al. (2002). Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2). J. Biol. Chem. 277, 13219–13228. doi:10.1074/jbc.M111465200

PubMed Abstract | CrossRef Full Text | Google Scholar

Moresi, V., Williams, A. H., Meadows, E., Flynn, J. M., Potthoff, M. J., Mcanally, J., et al. (2010). Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell. 143, 35–45. doi:10.1016/j.cell.2010.09.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Nerbonne, J. M. (2016). Molecular basis of functional myocardial potassium channel diversity. Card. Electrophysiol. Clin. 8, 257–273. doi:10.1016/j.ccep.2016.01.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Perera, S., Mankoo, B., and Gautel, M. (2012). Developmental regulation of MURF E3 ubiquitin ligases in skeletal muscle. J. Muscle Res. Cell. Motil. 33, 107–122. doi:10.1007/s10974-012-9288-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Roichman, A., Elhanati, S., Aon, M. A., Abramovich, I., Di Francesco, A., Shahar, Y., et al. (2021). Restoration of energy homeostasis by SIRT6 extends healthy lifespan. Nat. Commun. 12, 3208. doi:10.1038/s41467-021-23545-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Sadria, M., and Layton, A. T. (2021). Aging affects circadian clock and metabolism and modulates timing of medication. iScience 24, 102245. doi:10.1016/j.isci.2021.102245

PubMed Abstract | CrossRef Full Text | Google Scholar

Sherman, B. T., Hao, M., Qiu, J., Jiao, X., Baseler, M. W., Lane, H. C., et al. (2022). David: A web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216–W221. doi:10.1093/nar/gkac194

PubMed Abstract | CrossRef Full Text | Google Scholar

Tipparaju, S. M., Barski, O. A., Srivastava, S., and Bhatnagar, A. (2008). Catalytic mechanism and substrate specificity of the beta-subunit of the voltage-gated potassium channel. Biochemistry 47, 8840–8854. doi:10.1021/bi800301b

PubMed Abstract | CrossRef Full Text | Google Scholar

Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., et al. (2012). Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578. doi:10.1038/nprot.2012.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Trosclair, K., Si, M., Watts, M., Gautier, N. M., Voigt, N., Traylor, J., et al. (2021). Kv1.1 potassium channel subunit deficiency alters ventricular arrhythmia susceptibility, contractility, and repolarization. Physiol. Rep. 9, e14702. doi:10.14814/phy2.14702

PubMed Abstract | CrossRef Full Text | Google Scholar

Tur, J., Chapalamadagu, K. C., Manickam, R., Cheng, F., and Tipparaju, S. M. (2021). Deletion of Kvβ2 (AKR6) attenuates isoproterenol induced cardiac injury with links to solute carrier transporter SLC41a3 and circadian clock genes. Metabolites 11, 201. doi:10.3390/metabo11040201

PubMed Abstract | CrossRef Full Text | Google Scholar

Vyas, V. K., Parikh, P., Ramani, J., and Ghate, M. (2019). Medicinal chemistry of potassium channel modulators: An update of recent progress (2011-2017). Curr. Med. Chem. 26, 2062–2084. doi:10.2174/0929867325666180430152023

PubMed Abstract | CrossRef Full Text | Google Scholar

Wulff, H., Castle, N. A., and Pardo, L. A. (2009). Voltage-gated potassium channels as therapeutic targets. Nat. Rev. Drug Discov. 8, 982–1001. doi:10.1038/nrd2983

PubMed Abstract | CrossRef Full Text | Google Scholar